Immediate Impact
4 by Nobel laureates 6 from Science/Nature 62 standout
Citing Papers
Exploiting senescence for the treatment of cancer
2022 Standout
Heat shock proteins: Biological functions, pathological roles, and therapeutic opportunities
2022 Standout
Works of Michael Walton being referenced
A phase I trial of the heat shock protein 90 (HSP90) inhibitor 17-dimethylaminoethylamino-17-demethoxygeldanamycin (17- DMAG, alvespimycin) administered weekly
2007
A phase I trial of the selective oral cyclin-dependent kinase inhibitor seliciclib (CYC202; R-Roscovitine), administered twice daily for 7 days every 21 days
2006
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Michael Walton | 166 | 132 | 148 | 199 | 23 | 512 | |
| Wei‐Xia Peng | 85 | 98 | 229 | 126 | 33 | 549 | |
| Patricia Anne Davis | 127 | 28 | 176 | 209 | 29 | 609 | |
| Christian Dierkes | 75 | 90 | 146 | 161 | 23 | 550 | |
| Masayasu Kitano | 59 | 58 | 286 | 101 | 33 | 578 | |
| Takanori Kanematsu | 97 | 37 | 147 | 297 | 27 | 546 | |
| Christina Louise Derleth | 233 | 23 | 128 | 282 | 24 | 587 | |
| Rosanna Supino | 56 | 30 | 323 | 212 | 23 | 585 | |
| Ji Hyun Lee | 42 | 66 | 276 | 259 | 21 | 583 | |
| Antonella Ingrosso | 36 | 48 | 190 | 241 | 25 | 619 | |
| Florence Namour | 38 | 42 | 180 | 186 | 29 | 617 |
All Works
Login with ORCID to disown or claim papers
Loading papers...